Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 9, 2014, Pages 1132-1138

  Hooshmand, Babak ^a,b   Lökk, Johan ^c,d   Solomon, Alina ^a,b,e   Mangialasche, Francesca ^a,f   Miralbell, Julia ^g   Spulber, Gabriela ^c   Annerbo, Sylvia ^c   Andreasen, Niels ^b,d   Winblad, Bengt ^a,b,d   Cedazo Minguez, Angel ^b   Wahlund, Lars Olof ^c   Kivipelto, Miia ^a,b,d,e  

^a AGING RESEARCH CENTER   (Sweden)

^b KI Alzheimer's Disease Research Center   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF PERUGIA   (Italy)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cognition; CSF biomarkers; MRI; Older adults; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; DRUG DERIVATIVE; PEPTIDE FRAGMENT; TAU PROTEIN; VITAMIN D;

ALZHEIMER DISEASE; ARTICLE; BLOOD; BRAIN; CEREBROSPINAL FLUID; COGNITION; CSF BIOMARKERS; FEMALE; HISTOLOGY; HUMAN; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MRI.; OLDER ADULTS; ORGAN SIZE;

COGNITION; CSF BIOMARKERS; MRI.; OLDER ADULTS; VITAMIN D;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PEPTIDE FRAGMENTS; TAU PROTEINS; VITAMIN D;

EID: 84906214032     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu022     Document Type: Article

References (32)

1. Wang L, Hara K, Van Baaren JM, et al. Vitamin D receptor and Alzheimer's disease: A genetic and functional study. Neurobiol Aging. 2012;33:1844.e1-1844. e9. doi:10.1016/j. neurobiolaging.2011.12.038
2. Annweiler C, Schott AM, Berrut G, et al. Vitamin D and ageing: Neurological issues. Neuropsychobiology. 2010;62:139-150
3. Chu MP, Alagiakrishnan K, Sadowski C. The cure of ageing: Vitamin D-magic or myth?. Postgrad Med J. 2010;86:608-616
4. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition?. A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007;460:202-205
5. Etgen T, Sander D, Bickel H, Sander K, Forstl H. Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-Analysis. Dement Geriatr Cogn Disord. 2012;33:297-305
6. Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: A systematic review and meta-Analysis. Neurology. 2012;79:1397-1405. doi:10.1159/000339702
7. Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74:18-26
8. Annweiler C, Rolland Y, Schott AM, et al. Higher vitamin D dietary intake is associated with lower risk of Alzheimer's disease: A 7-year follow-up. J Gerontol A Biol Sci Med Sci. 2012;67:1205-1211. doi:10.1212/WNL.0b013e3181beecb7
9. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci. 2011;66:59-65. doi:10.1093/gerona/gls107
10. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131-144. doi:10.1093/gerona/glq185
11. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119-128. doi:10.1038/nrneurol.2010.4
12. Miralbell J, Spulber G, Hooshmand B, et al. Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs. J Alzheimers Dis. 2012;29:741-749. doi:10.1016/S1474-4422(09)70299-6
13. Andersson C, Blennow K, Johansson SE, et al. Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment. Dement Geriatr Cogn Disord. 2007;23:87-95. doi:10.3233/JAD-2012-111553
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944
15. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246
16. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci. 2009;64:888-895. doi:10.1093/gerona/glp032
17. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170:1135-1141. doi:10.1001/archinternmed.2010.173
18. Annweiler C, Schott AM, Allali G, et al. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study. Neurology. 2010;74:27-32. doi:10.1212/WNL.0b013e3181beecd3
19. Slinin Y, Paudel M, Taylor BC, et al. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci. 2012;67:1092-1098
20. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14:1032-1040
21. Masoumi A, Goldenson B, Ghirmai S, et al. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2009;17:703-717. doi:10.3233/JAD-2009-1080
22. Mizwicki MT, Menegaz D, Zhang J, et al. Genomic and nongenomic signaling induced by 1á,25(OH)2-vitamin D3 promotes the recovery of amyloid- phagocytosis by Alzheimer's disease macrophages. J Alzheimers Dis. 2012;29:51-62. doi:10.3233/JAD-2012-110560
23. Durk MR, Chan GN, Campos CR, et al. 1a,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. J Neurochem. 2012;123:944-953. doi:10.1111/jnc.12041
24. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N. Nutrient intake and plasma β-Amyloid. Neurology. 2012;78:1832-1840. doi:10.1212/WNL. 0b013e318258f7c2
25. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on Diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:257-262. doi:10.1016/j.jalz.2011.03.004
26. Miller JW. Vitamin D and cognitive function in older adults: Are we concerned about vitamin D-mentia?. Neurology. 2010;74:13-15. doi:10.1212/WNL.0b013e3181c719a2
27. Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385-393. doi:10.1001/jama.2009.1064
28. Clinical Trials.gov. VITAL-Cog: A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline. 2012. http://clinicaltrials. gov/ct2/show/NCT01669915. Accessed August 27, 2013
29. Clinical Trials.gov. DIET-D: DIetary Supplements, Executive func-Tions and Vitamin D. 2012. http://clinicaltrials.gov/ct2/show/NCT01708005. Accessed August 25, 2013
30. Clinical Trials.gov. MERE: Alzheimer's Disease and Related Disorders. 2011. http://clinicaltrials.gov/ct2/show/NCT01315704. Accessed August 27, 2013
31. Clinical Trials.gov. AD-IDEA: Alzheimer's Disease - Input of Vitamin D With mEmantine Assay. 2011. http://clinicaltrials.gov/ct2/show/NCT01409694?term= ad-idea&rank=1. Accessed November 7, 2012
32. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's disease: Clinical trials and drug development. Lancet Neurol. 2010;9:702-716. doi:10.1016/S1474-4422(10)70119-8